Study of AggreGuide A-100 (ADP) Assay
Not Applicable
Completed
- Conditions
- Platelet Dysfunction Due to DrugsRisk Factor, Cardiovascular
- Interventions
- Drug: P2Y12 inhibitorDevice: Platelet function test
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 280
- Registration Number
- NCT03111420
Aggreguide A-100 ADP Assay Evaluation
Completed
- Conditions
- ADP BlockersPlatelet Aggregation
- Interventions
- Other: platelet aggregation measurement
- First Posted Date
- 2014-04-14
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT02112539
- Locations
- 🇺🇸
Juno Research, Houston, Texas, United States
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Completed
- Conditions
- Platelet Dysfunction Due to Aspirin Ingestion
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Aggredyne, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT01915407
- Locations
- 🇺🇸
Aggredyne, Inc., Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath